Note: Ingredients listed on restricted chemical lists
EC/CAS
9004-65-3
Name of the chemical
methylhydroxypropylcellulose
Concentration
N/A
EC/CAS
209-150-3
Name of the chemical
Aluminium, zinc, magnesium and calcium stearates
Concentration
N/A
General Information
Revision date
2009-09-23
Product name
Zidovudine Tablets
Product Synonyms
None
Chemical name
Not determined
Icons in SDS
Company Information
company name
Greenstone LLC
GHS Information
Signal word
WARNING
Section 2
SECTION 2: Hazards identification
Appearance: White tablets
Signal word
WARNING
Hazard statements
Suspected of causing cancer. Suspected of causing genetic defects. Suspected of damaging the unborn child.
Additional information
Long Term: Repeat-dose studies in animals have shown a potential to cause adverse effects on liver, blood and blood forming organs, heart and skeletal muscle. Known Clinical Effects: Adverse effects associated with therapeutic use include blood system changes, liver effects, heart muscle damage (cardiomyopathy). EU Indication of danger: Mutagenic: Category 2 Carcinogenic: Category 2 Toxic to Reproduction: Category 2 EU Risk Phrases: R45 - May cause cancer. R46 - May cause heritable genetic damage. R61 - May cause harm to the unborn child. R64- May cause harm to breastfed babies. Australian Hazard Classification For a more detailed discussion of potential health hazards and toxicity see Section 11. Note: This document has been prepared in accordance with standards for workplace safety, which require the inclusion of all known hazards of the active substance or its intermediates regardless of the potential risk. The precautionary statements and warnings included may not apply in all cases. Your needs may vary depending upon the potential for exposure in your workplace.
Hazardous Ingredients
Non-Dangerous Goods (NOHSC):
